DZHK studies and associated studies

Suchen, sortieren und filtern

Munich Remote SpO2 and Heart Rate Assessment in Covid-19 patients (MR SPOC)

In the MR SPOC trial, modern smartwatches continuously measure ECG, pulse, and oxygen saturation in the blood of COVID-19 patients and transfer these data into the hospital to get treatment advice.

Recruiting status
Recruiting planned
Principal Investigators
Moritz Sinner (München)
600 0 München Frühe klinische Studie Herzmuskelerkrankungen

Effect of anticoagulation therapy on clinical outcomes in COVID-19 (COVID-PREVENT)

The Germany-wide COVIDPREVENT trial is investigating whether the administration of the blood thinner Rivaroxaban can reduce thrombotic events such as heart attack, pulmonary embolism or stroke in CoVID-19 patients.

Recruiting status
Recruiting planned
Principal Investigators
Ulf Landmesser (Berlin)
380 0 Berlin,Heidelberg,Neuperlach,Dresden,München,Herne,Greifswald,Frankfurt am Main,Oberhavel,Göttingen Leitlinien-relevante Studie Herzmuskelerkrankungen

Stopping ACE-inhibitors in COVID-19 (ACEI-COVID-19)

The study investigates the effects on the course of COVID-19 disease when ACE inhibitors are paused or replaced by antihypertensives with a different mechanism of action in COVID-19 patients.

Recruiting status
Recruiting planned
Principal Investigators
Steffen Massberg (München) Konstantinos Rizas (München)
804 0 München,Innsbruck,Weilheim,Bad Tölz,Memmingen,Weiden,Augsburg,Zams,Hall,Schwaz,Kufstein,St. Johann,Klagenfurt Leitlinien-relevante Studie Herzmuskelerkrankungen

TranslatiOnal Registry for CardiomyopatHies-Plus (TORCH-Plus-DZHK21)

TORCH-Plus is a large-scale prospective data & biomaterial repository of patients with non-ischemic cardiomyopathies.

Recruiting status
Recruiting planned
Principal Investigators
Benjamin Meder (Heidelberg/Mannheim)
4340 EUR 3.004.004,22 € Heidelberg,Frankfurt am Main,Mannheim,Greifswald,München,Berlin,Göttingen,Hamburg,Kiel,Lübeck,Hannover,Mainz,Bad Nauheim Register Herzmuskelerkrankungen

Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assist Tissue in Terminal Heart Failure (BioVAT-DZHK20)

BioVAT-HF-DZHK20 trial is investigating under which conditions engineered human myocardium is safe to use in the treatment of patients with end-stage heart failure.

Recruiting status
Recruiting planned
Principal Investigators
Wolfram-Hubertus Zimmermann
53 EUR 1.192.062 € Göttingen,Lübeck,Bad Oeynhausen Frühe klinische Studie Schlaganfall

Phosphodiesterase-5 inhibition in patients with combined pre- and postcapillary pulmonary hypertension due to heart failure with preserved ejection fraction (PASSION)

The associated DZHK study PASSION investigates whether the drug Tadalafil can reduce cardiac-related hospital admissions and mortality of patients with pulmonary hypertension due to heart failure.

Recruiting status
Recruiting ongoing
Principal Investigators
Marius Hoeper (MHH), Stephan Rosenkranz (UK)
10/2018 356 DZHK-assoziierte Studie (keine finanzielle Förderung) Hannover,Köln,Marburg,Heidelberg,Dresden,Leipzig,Würzburg,Berlin,Gießen,Greifswald,Homburg/Saar,Mainz,Regensburg,München,Immenhausen,Großhansdorf,Magdeburg,Mönchengladbach,Konstanz,Bremen,Bonn,Erfurt,Ulm,Donaueschingen Leitlinien-relevante Studie

Prediction of Acute Coronary Syndrome in Acute Ischemic Stroke (PRAISE-DZHK19 I DZNEB001)

The aim of the study PRAISE-DZHK19 I DZNEB001 is to establish a clinical algorithm that enables the prediction of acute coronary syndrome or heart attack in stroke patients.

Recruiting status
Recruiting ongoing
Principal Investigators
Matthias Endres, Ulf Landmesser, Christian Nolte (Berlin)
10/2018 251 EUR 542.644,91 Berlin,Leipzig,Greifswald,Hamburg,Lübeck,Fulda,Göttingen,Osnabrück,Bonn,Frankfurt am Main,Mannheim,Heidelberg,Tübingen,München,Erlangen,Celle,Bad Neustadt,Dresden Frühe klinische Studie Schlaganfall

Effect of Metformin in insulin resistant patients with heart failure with reduced ejection fraction (METRIS-HF-DZHK18)

The METRIS-HF-DZHK18 trial aims to find out whether improved energy metabolism can increase heart efficiency in patients with cardiac insufficiency.

Recruiting status
Recruiting ongoing
Principal Investigators
Wolfram Döhner (Berlin), Burkert Pieske (Berlin), Tim Friede (Göttingen)
09/2018 88 EUR 973.012,80 Berlin Frühe klinische Studie Herzschwäche

Home-Based Screening for Early Detection of Atrial Fibrillation in Primary Care Patients Aged 75 Years and Older (SCREEN AF-DZHK15)

The SCREEN-AF study aims to improve the early detection of atrial fibrillation using a new “rhythm patch” with an integrated ECG recording unit which is applied to the patient’s chest.

Recruiting status
Recruiting complete, follow-up complete
Principal Investigators
Rolf Wachter, Eva Hummers-Pradier (Göttingen), Jeff Healey, David Gladstone (Canadian Stroke Prevention Intervention Network, Kanada)
12/2017 267 EUR 725.674,19 Göttingen,Hamburg Leitlinien-relevante Studie Vorhofflimmern

Evaluating the benefit of concurrent tricuspid valve repair during mitral surgery (CTSN-TVR-DZHK14)

The aim of the study is to clarify whether it is beneficial to operate the tricuspid valve in the right heart at the same time if the mitral valve is defective, even if the right heart valve is not yet very leaky.

Recruiting status
Recruiting complete, follow-up continuing
Principal Investigators
Volkmar Falk (Berlin); Annetine C. Gelijns (Icahn School of Medicine at Mount Sinai, NY, USA)
06/2017 76 EUR 895.351 Berlin,Leipzig,Jena,Hamburg,Lübeck,Bad Oeynhausen,Göttingen,Frankfurt am Main,Bad Krozingen,München Leitlinien-relevante Studie Herzklappenerkrankungen

Validation of Cardiovascular Magnetic Resonance against Invasive Haemodynamics in Patients with Heart Failure with Preserved Ejection Fraction (Decipher HFpEF-DZHK12)

The DECIPHER HFpEF-DZHK12 study investigates whether diastolic heart failure can be better diagnosed and its causes clarified with the help of cardiovascular magnetic resonance imaging (CMR).

Recruiting status
Recruiting ongoing
Principal Investigators
Eike Nagel (Frankfurt)
01/2018 185 EUR 811.793,58 Frankfurt am Main,Berlin,Heidelberg,Göttingen,Mainz Frühe klinische Studie Herzschwäche

Exercise Training in Patients with Left Ventricular Assist Device (Ex-VAD-DZHK11)

This study is examining whether a tailored physical exercise can improve the fitness and quality of life of patients with an artificial heart.

Recruiting status
Recruiting ongoing
Principal Investigators
Frank Edelmann (Berlin), Burkert Pieske (Berlin), Martin Halle (München), Volkmar Falk (Berlin)
12/2017 66 EUR 640.523,21 Berlin,Leipzig,Hamburg,Düsseldorf,München Frühe klinische Studie Herzschwäche

Randomized Trial of TAVI versus SAVR in Patients with Symptomatic Severe Aortic Valve Stenosis and Intermediate Risk of Mortality (DEDICATE-DZHK6)

The DEDICATE-DZHK6 study is investigating whether surgical or transcatheter aortic valve implantation is the superior long-term treatment option for patients with severe aortic valve stenosis.

Recruiting status
Recruiting ongoing
Principal Investigators
Stefan Blankenberg, Moritz Seiffert (Hamburg)
05/2017 1600 EUR 3.966.680,61 Hamburg,Dresden,Leipzig,Jena,Berlin,Lübeck,Kiel,Hannover,Bad Oeynhausen,Gießen,Göttingen,Düsseldorf,Bochum,Münster,Köln,Aachen,Mainz,Bad Nauheim,Heidelberg,Stuttgart,Bad Krozingen,München,Ulm,Erlangen,Regensburg,Bad Neustadt,Frankfurt am Main,Halle (Saale) Leitlinien-relevante Studie Herzschwäche

Ultrasound evaluation of the inferior vena cava in addition to clinical assessment to guide decongestion in acute decompensated heart failure: a pilot study (CAVA-ADHF-DZHK10)

This trial is examining whether an ultrasound evaluation of the inferior vena cava in acute decompensated heart failure (ADHF) with congestion can be implemented in hospitals’ everyday routine in a large number of patients.

Recruiting status
Recruiting complete, follow-up continuing
Principal Investigators
Alexander Jobs (Lübeck), Holger Thiele
07/2017 388 EUR 1.097.524,51 Lübeck,Leipzig,Berlin,Greifswald,Hamburg,Kiel,Göttingen,Mainz,Frankfurt am Main,Mannheim,München,Würzburg Frühe klinische Studie Herzschwäche

Cardiovascular magnetic resonance real time exercise stress testing in heart failure with preserved ejection fraction (HFpEF-stress-DZHK17)

Researchers will test in this trial whether the newly developed real-time CMR technology is suitable for the early and safe diagnosis of HFpEF.

Recruiting status
Study completed
Principal Investigators
Andreas Schuster (Göttingen)
08/2017 70 EUR 317.879,99 Göttingen Frühe klinische Studie Herzschwäche

Left atrial appendage CLOSURE in patients with Atrial Fibrillation at high risk of stroke and bleeding compared to medical therapy (CLOSURE-AF-DZHK16)

The DZHK study CLOSURE-AF compares the benefit of the left atrial appendage closure with the best possible drug therapy for high-risk patients with atrial fibrillation.

Recruiting status
Recruiting ongoing
Principal Investigators
Ulf Landmesser (Berlin), Ingo Eitel (Lübeck), Leif-Hendrik Boldt (Berlin)
03/2018 1512 EUR 6.972.940,28 Berlin,Dresden,Leipzig,Gera,Jena,Zwickau,Chemnitz,Brandenburg,Hennigsdorf,Greifswald,Rostock,Hamburg,Lübeck,Kiel,Heide,Bremen,Herford,Detmold,Gießen,Fulda,Göttingen,Wuppertal,Essen,Mainz,Frankfurt am Main,Kaiserslautern,Mannheim,Heidelberg,Tübingen,Freudenstadt,Villingen-Schwenningen,Bad Krozingen,München,Dachau,Ulm,Erlangen,Coburg,Würzburg,Erfurt,Halle (Saale),Regensburg Leitlinien-relevante Studie Vorhofflimmern

SPIRonolactone In the Treatment for Heart Failure (SPIRIT-HF-DZHK8)

The SPIRIT-HF-DZHK8 study investigates whether the drug spironolactone can reduce the number of people with preserved ejection fraction who end up in hospital and the number of people who die from heart failure.

Recruiting status
Recruiting ongoing
Principal Investigators
Burkert Pieske, Frank Edelmann (Berlin)
11/2018 1300 EUR 7.014.000,21 Berlin,Elsterwerda,Bernau,Greifswald,Lübeck,Kiel,Bremen,Gießen,Göttingen,Mainz,Bad Nauheim,Mannheim,Heidelberg,München,Halle (Saale) Leitlinien-relevante Studie Herzschwäche

Implantable cardiac monitors in high-risk post-infarction patients with cardiac autonomic dysfunction (SMART-MI-DZHK9)

DZHK researchers from Munich test whether the use of implantable cardiac monitors with home monitoring function is more effective than conventional follow-up for detecting serious arrhythmic events in a newly identified high-risk group of patients.

Recruiting status
Recruiting ongoing
Principal Investigators
Axel Bauer, Stefan Kääb, Steffen Massberg (München)
05/2016 400 EUR 1.876.101,15 München,Kiel,Tübingen,Leipzig,Berlin,Greifswald,Hamburg,Lübeck,Göttingen,Homburg,Karlsruhe,Regensburg,Wuppertal,Dresden,Essen,Münster,Aachen,Mainz,Wiesbaden,Mannheim,Heidelberg,Bernried,Füssen,Nürnberg,Weiden i.d. O Frühe klinische Studie Durchblutungsstörungen des Herzmuskels

Apixaban versus Phenprocoumon: oral anticoagulation plus antiplatelet therapy in patients with acute coronary syndrome and atrial fibrillation (APPROACH-ACS-AF-DZHK7)

DZHK researchers compare two therapies in patients with atrial fibrillation, who have also had a heart attack in order to find out which therapy leads to less bleedings.

Recruiting status
Recruiting complete, follow-up continuing
Principal Investigators
Reza Wakili, Steffen Massberg (München)
07/2016 400 EUR 838.671 München,Coburg,Berlin,Greifswald,Rostock,Göttingen,Mainz,Heidelberg,Kiel,Essen,Aachen,Mannheim,Lüdenscheid Leitlinien-relevante Studie Durchblutungsstörungen des Herzmuskels

Intravenous iron in patients with systolic heart failure and iron deficiency to improve morbidity and mortality (FAIR-HF2-DZHK5)

The FAIR-HF2 study will be assessing whether treatment with intravenously administered ferric carboxymaltose improves the chances of survival and helps to reduce the number of hospitalisations of heart failure patients diagnosed with iron deficiency.

Recruiting status
Recruiting ongoing
Principal Investigators
Mahir Karakas (Hamburg), Stefan Anker (Berlin)
03/2017 1200 EUR 6.578.978,32 Göttingen,Hamburg,Berlin,Lübeck,Kiel,Magdeburg,Mainz,Bad Nauheim,Homburg,Mannheim,Heidelberg,Ulm,Nürnberg,Jena,Greifswald,Rostock,Bremen,Mönchengladbach,Remscheid,München,Mühldorf,Bad Friedrichshall,Dresden,Halle (Saale),Burg Leitlinien-relevante Studie Herzschwäche

Immediate unselected coronary angiography versus delayed triage in survivors of out-of-hospital cardiac arrest without ST-segment elevation (TOMAHAWK-DZHK4)

TOMAHAWK compares the effects of immediate coronary angiography to delayed intervention in survivors of cardiac arrest who occurred outside a hospital and without ST elevation.

Recruiting status
Recruiting complete, follow-up continuing
Principal Investigators
Steffen Desch (Lübeck), Holger Thiele
11/2016 545 EUR 2.815.469,11 Lübeck,Leipzig,Jena,Berlin,Greifswald,Buchholz,Kiel,Flensburg,Schwalmstadt,Göttingen,Mönchengladbach,Herne,Mainz,Frankfurt am Main,Bad Nauheim,Langen,Limburg,Ludwigshafen,Mannheim,Heidelberg,Bad Krozingen,München,Neumarkt,Regensburg,Würzburg,Erfurt,Bad Berka,Essen,Tübingen Leitlinien-relevante Studie Herzstillstand

Early versus emergency left ventricular assist device implantation in patients awaiting cardiac transplantation (VAD-DZHK3)

This study is expected to deliver guideline-relevant findings for the future treatment of patients with terminal heart failure.

Recruiting status
Recruiting ongoing
Principal Investigators
Volkmar Falk, Christoph Knosalla (Berlin), Gerd Hasenfuß, Tim Friede (Göttingen)
07/2015 200 EUR 3.102.028,87 Berlin,Hamburg,Kiel,Bad Nauheim,Heidelberg,München,Leipzig,Jena,Bad Oeynhausen,Hannover,Bad Krozingen,Göttingen,Magdeburg Leitlinien-relevante Studie Herzschwäche

Systolic dysfunction to congestive heart failure cohort study (TransitionCHF-DZHK2)

This cohort study explores ways of predicting when decreased cardiac performance without symptoms will develop into a clinically manifest disease.

Recruiting status
Recruiting ongoing
Principal Investigators
Gerd Hasenfuß, Rolf Wachter, Frank Edelmann (Göttingen)
12/2014 1000 EUR 1.957.843 Göttingen,Berlin,Greifswald,Hamburg,Mainz,Frankfurt am Main,Heidelberg,München,Mannheim,Kiel,Bad Nauheim,Würzburg Kohorte Herzschwäche

Translational registry for cardiomyopathies (TORCH-DZHK1)

As a translational registry for cardiomyopathies, TORCH-DZHK1 collects data and biosamples from 2,300 patients with heart muscle diseases.

Recruiting status
Recruiting complete, follow-up complete
Principal Investigators
Hugo Katus (Heidelberg), Wolfgang Hoffmann (Greifswald)
12/2014 2300 EUR 1.290.098,47 Heidelberg,Berlin,Greifswald,Hamburg,Lübeck,Göttingen,Mainz,Frankfurt am Main,Bad Nauheim,Mannheim,München,Hannover,Kiel Register Herzmuskelerkrankungen

Revacept, a novel inhibitor of platelet adhesion in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention (REVACEPT-PCI in CAD)

The study objective is to evaluate the efficacy and safety of treatment of the drug Revacept versus placebo in patients with stable coronary artery disease undergoing PCI.

Recruiting status
Recruiting complete, follow-up continuing
Principal Investigators
Adnan Kastrati, Steffen Massberg (München)
11/2017 332 EUR 845.655 München,Frankfurt am Main,Mainz,Berlin,Tübingen Frühe klinische Studie

Continuation of the cohort “inflammatory cardiomyopathy” of the collaborative research centre transregio 19 (SFB/TR19) as “SFB/TR19 Plus”

The cohort study SFB/TR 19 plus investigates new diagnostic and treatment approaches for inflammatory cardiomyopathies.

Principal Investigators
Stephan B. Felix (Greifswald)
06/2015 500 0 Greifswald Kohorte

Prospective, randomized trial of ticagrelor versus prasugrel in patients with acute coronary syndrome (ISAR-REACT 5)

This study compares two agents used to inhibit blood clotting - ticagrelor and prasugrel. The hypothesis that ticagrelor is superior to prasugrel for the treatment of patients with acute coronary syndrome will be examined in relation to clinical outcomes.

Recruiting status
Recruiting complete
Principal Investigators
Adnan Kastrati, Stefanie Schüpke (München)
09/2013 4000 EUR 948.739 München Leitlinien-relevante Studie

Culprit Lesion Only PCI Versus Multivessel PCI in Cardiogenic Shock (CULPRIT-SHOCK)

Prospective randomized multicenter study comparing immediate multivessel revascularization by PCI versus culprit lesion PCI with staged non-culprit lesion revascularization in patients with acute myocardial infarction complicated by cardiogenic shock.

Recruiting status
Recruiting complete
Principal Investigators
Holger Thiele (Lübeck)
04/2013 706 DZHK-assoziierte Studie (keine finanzielle Förderung) Lübeck,Erfurt,Lippe-Detmold,München,Langen-Seligenstadt,Leipzig,Magdeburg,Göttingen,Coburg,Mannheim,Greifswald,Bremen,Bambek,Würzburg,Düsseldorf,Regensburg,Wiesbaden Leitlinien-relevante Studie

SORT-AF Supervised Obesity Reduction Trial for AF Ablation Patients (SORT-AF)

Prospective randomized multicenter study to evaluate the impact of weight reduction on AF recurrence after AF ablation in obese patients.

Recruiting status
Recruiting complete, follow-up complete
Principal Investigators
Stephan Willems (Hamburg), Daniel Steven (Köln)
01/2014 140 DZHK-assoziierte Studie (keine finanzielle Förderung) Lübeck,Köln,Hamburg Leitlinien-relevante Studie

Evaluation of the safety and efficacy of the OPTIMIZER ® system in subjects with moderate-to-severe heart failure (FIX-HF-5C)

The study was designed to evaluate both safety and efficacy of the OPTIMIZER system in patients with moderate to severe heart failure.

Recruiting status
Recruiting complete
Principal Investigators
Gerd Hasenfuß (Göttingen)
10/2014 160 DZHK-assoziierte Studie (keine finanzielle Förderung) Göttingen,Essen,Bad Bevensen,Berlin,Hamburg,Mannheim,München Leitlinien-relevante Studie

Non-vitamin K antagonist oral anticoagulants in patients with atrial high rate episodes (NOAH-AFNET 6)

NOAH-AFNET 6 evaluates the potential benefit of oral anticoagulation treatment in patients with atrial high rate episodes.

Recruiting status
Recruiting ongoing
Principal Investigators
Paulus Kirchhof (Birmingham, Münster)
06/2016 3400 0 Münster Leitlinien-relevante Studie

National register for congenital heart defects (NRCHD)

The person-based register records data from patients of all age groups and with all kinds of congenital heart defects across Germany.

Recruiting status
Recruiting ongoing
Principal Investigators
Ulrike Bauer, Thomas Pickardt (Berlin)
2000 70000 0 Berlin,Aachen,augsburg,Bad Oeynhausen,Bochum,Bonn,Bremen,Chemnitz,Coesfeld,Datteln,Dortmund,Dresden,Duisburg,Düsseldorf,Eichwalde,Erfurt,Erlangen,Frankfurt am Main,Freiburg,Fulda,Fürth,Gelsenkirchen,Greifswald,Gießen,Göttingen,Hagen,Halle (Saale),Hamburg,Hannover,Heidelberg,Homburg,Ibbenbüren,Jena,Kaiserslautern,Karlsruhe,Kassel,Kempten,Kiel,Krefeld,Köln,Landshut,Leipzig,Lingen,Wittenberg,Lübeck,Mainz,Mannheim,Memmingen,München,Münster,Oberhausen,Oldenburg,Pinneberg,Ravensburg,Regensburg,Rheinfelden-Herten,Rosenheim,Rothenburg,Saalfeld,Sainkt Augustin,Stuttgart,Traunstein,Tübingen,Ulm,Vechta,Weimar,Wuppertal,Würzburg Register

No entries found for search criteria